Stepscan Technologies Inc.

Stepscan Technologies is transforming how mobility is measured and understood—advancing innovation at the intersection of medical technology and care delivery. Our patented pressure-sensitive flooring system and proprietary analysis software provide clinicians and researchers with precise, real-time data on balance, gait, and functional mobility. Stepscan is trusted for its objectivity, accuracy, and flexibility across diverse clinical and research settings. A Class I medical device with both Health Canada and the US FDA, the Stepscan® system is currently in use for: - Fall risk screening - Diabetic foot ulcer prevention - Stroke and neuro rehab - Clinical research and performance monitoring Stepscan's clients include leading institutions such as the Royal Children's Hospital (Melbourne), Veterans Affairs Canada and the U.S. Department of Veterans Affairs, the University of California, and others across North America. Now entering a new chapter of growth, Stepscan is scaling beyond med tech manufacturing into integrated care delivery through the acquisition of physiotherapy clinics. Our goal: to build a connected network that blends innovative technology with personalized rehabilitation—supporting better outcomes for patients, providers, and communities. Whether applied in healthcare, sports science, defense, or research, Stepscan is shaping the future of movement intelligence.

• Employees 4
• Founded 2011
• Annual Revenue $1193000
• Total Funding $2000000